Skip to main content
Caplight Logo









Prominex, Inc.

Prominex, Inc.

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://prominex.com/

Last Round

Series B

Extension

Feb 24, 2020

Total Funding Raised

$19.2M

Company Overview

Prominex, Inc. is a biotechnology company that develops rapid, point-of-care molecular diagnostic solutions for infectious disease testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Non-AI

Keywords

point-of-care diagnosticsmolecular diagnosticsPOC testinginfectious disease testingmultiplexed testingrapid diagnosticsrazor-and-blade modeldiagnostic instrumentassay cartridgesmedical devicenear-patient testingmolecular amplificationlateral-flow detectionclinical diagnosticsrapid test

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Prominex, Inc. Comparables

Compare Prominex, Inc. with similar companies based on industry and business-model similarity.

Prominex, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Anavasi Diagnostics
85%
Aptitude Medical
80%
Visby Medical
80%

Prominex, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionFeb 24, 2020
Series BMay 31, 2019
Series A ExtensionSep 13, 2018
Series AJan 5, 2018

Key People

Founding team and executive leadership

Paul Thomas

Chief Executive Officer

Executive Team

Prominex, Inc. Investors

Notable investors and investment history

Prominex, Inc. investors
InvestorRounds
Casdin CapitalSeries B, Series A, Series B Extension, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 3, 2025

    Monthly visitors grew 269% MoM, from 325 to 1.2K.

  • Feb 4, 2025

    Grew 27% QoQ, from 11 to 14 employees.

Prominex, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Prominex, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Prominex, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range16
Year Founded2018
Last FundingFeb 24, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?